Posts tagged “Management/Leadership”
Christopher A. Viehbacher, CEO of Sanofi, and Alan Mulally, former CEO of Ford Motor Company, will join six other top executives on Thursday to discuss the secrets of successful transformation at the annual conference in Raleigh.
Vivek Wadhwa: Experts excel in looking backwards, protecting their turf, and saying what their clients want to hear. Their short-term predictions are sometimes right, but they are almost always wrong in forecasting any more-distant future.
The Research Triangle Cleantech Cluster has approved a new two-year strategic plan to accelerate the region's cleantech economy and formed a 22-member advisory council to advise and implement it.
J. Keith Mularski's world has expanded greatly since he stopped selling discount furniture to join the FBI in 1998. Since then, the supervisory special agent has been recognized as a foremost expert on cybercrime.
The management shifts at the RTP-based company over the past eight months are helping the firm grow to new levels.
Renowned physician Dr. Russell Greenfield - a regular contributor to The Dr. Oz Show and an author - has been named the new medical director for PurThread in North Carolina.
The Cary-based company has raised a total of $7 million this month and has earmarked the equity to accelerate business growth and open a new global headquarters out west.
The Certified Educational Chief Technology Officer (CeCTO) program finished its fourth cohort and welcomed 20 new CeCTOs and 11 Leaders of the 21st Century last week in Chapel Hill.
Mark Loughridge, the longest-serving CFO in IBM's 102-year history, managed the company's finances as it shifted to high- margin products -- an effort to steadily increase profits at the cost of sales growth.
Vikram Natarajan, who was part of Medfusion for five years before Intuit bought the company in 2010, is returning as chief technology officer. Read what Natarajan and founder Steve Malik plan to do with the company.
There's a big disconnect between the attributes that CEOs value and those that VCs emphasize. Read about these and other findings from a report released from the National Venture Capital Association.
Entegrion's executive changes come as the RTP firm prepares its freeze-dried human plasma for clinical trials along with other R&D efforts